Inhaled Nitric Oxide Delivery Systems Market: Current Analysis and Forecast (2021-2027)

$3999$7577

Emphasis on Type (Paediatrics, Adults); Application (Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure, Chronic Obstructive Pulmonary Disease, and Others); Product Type (Disposables, Systems); End-Users (Hospital, Ambulatory Centers, Clinics); Region and Country

Published:

Feb-2022

Pages:

229

Table:

43

Figure:

137

Report ID:

UMHE21664

Geography:

Clear
  Get a Free Sample
SKU: UMHE21664 Categories: ,
Report Description
Table of content
Research Methodology

Report Description

Global Inhaled Nitric Oxide Delivery Systems Market is anticipated to grow with an elevated CAGR of around 6% over the forecast period (2021-2027). Inhaled Nitric Oxide is a minimally invasive therapy that is used for the treatment of conditions associated with reversible pulmonary vasoconstriction and pulmonary hypertension. It is a selective pulmonary Vaso-dilator, which reduces pressures in the pulmonary artery and improves arterial oxygenation in infants and adults with respiratory failures.

The growing adoption of inhaled nitric oxide delivery systems can be attributed to the rising prevalence of various respiratory diseases. Some of the most common respiratory diseases include lung cancer, tumors airway stenosis, pneumonia, bronchitis, lung infections, and chronic obstructive Pulmonary Disease (COPD). Almost 3.3 million people succumb to COPD every year, as per the World Health Organization. Also, according to the American Cancer Society estimates, in the U.S., nearly 235,070 new cases of lung cancer and tumors were detected in 2018. This in turn is positively impacting the inhaled nitric oxide delivery systems market globally.

Furthermore, the inhaled nitric oxide delivery systems market is anticipated to grow on account of the growing adoption of the inhaled nitric oxide delivery systems and favorable government initiatives along with the expedited FDA approvals. For example, in January 2020, As per Vero Biotech LLC, the FDA has approved the Genosyl inhaled nitric oxide (iNO) gas delivery system. Genosyl is a tankless, portable iNO system that eliminates the need for large nitric oxide tanks. Furthermore, the advantages offered by inhaled nitric oxide and the use of iNO as an effective treatment against the SARS-CoV-2 virus are some of the other factors driving the market across the globe.

% of Patients affected by Respiratory disease in the United Kingdom, 2020

Inhaled Nitric Oxide Delivery Systems Market

Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED, Bellerophon Therapeutics, Praxair Technology Inc., are some of the prominent players operating in the inhaled nitric oxide delivery systems market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with inhaled nitric oxide delivery systems.

Insights Presented in the Report
“Amongst Type, paediatrics segment holds the major share”
Based on type, the inhaled nitric oxide delivery systems market is bifurcated into paediatrics and adults. The paediatrics segment accounted for the largest market share in 2020 it is estimated that it will exhibit the highest CAGR during the forecast period owing to the growing prevalence of neonatal diseases and increased adoption of inhaled nitric oxide as an effective treatment for diseases including Hypoxic Respiratory Failure. Furthermore, the supportive governmental norms and favorable reimbursement scenario are also some of the prominent reasons responsible for the growth of this segment.

“Amongst Application, hypoxic respiratory failure segment holds the major share”
Based on application, the inhaled nitric oxide delivery systems market is segmented into hypoxic respiratory failure, acute hypoxemic respiratory failure, chronic obstructive pulmonary disease, and others. The hypoxic respiratory failure segment occupied the major share of the inhaled nitric oxide delivery systems market in 2020 and it is expected to grow with substantial CAGR in the upcoming years owing to the growing prevalence of HRF, cost-effectiveness, and high efficacy of the inhaled nitric oxide therapy. For instance, in the United States, the death of nearly 18 in 1000 babies is because of the HRF and the majority of them are born prematurely.

“Amongst Product Type, disposables segment holds the major share”
Based on product type, the market is divided into disposables and systems. In 2020, the disposable segment grabbed the considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to some of the factors such as a larger consumer base, lower cost of raw materials and abundant resources availability. Furthermore, the growing demand for disposables is also because of the presence of a large number of manufacturers and the growing demand for nebulizer masks in hospitals.

“Amongst End-Users, hospital segment holds the major share”

Based on end-users, the market is fragmented into hospital, ambulatory centers, and clinics. In 2020, the hospital segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The growth of this segment is attributed to the growing utilization of these products in hospitals as they have advanced and well-established healthcare infrastructure. In addition, the increasing preference of patients for hospitals-based procedures, availability of skilled healthcare professionals to track device operations, and presence of emergency department are some of the prominent factors boosting the growth of this segment.

“North America represents one of the largest markets of inhaled nitric oxide delivery systems market”
For a better understanding of the market dynamics of the inhaled nitric oxide delivery systems market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. Asia-Pacific constitutes a major market for the inhaled nitric oxide delivery systems market industry and generated revenue of USD XX Million in 2020. However, North America is expected to grow rapidly in the upcoming years.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry

Customization Options:
The global inhaled nitric oxide delivery systems market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1Market Definitions
1.2Objective of the Study
1.3Limitation
1.4Stake Holders
1.5Currency Used in Report
1.6Scope of the Global Inhaled Nitric Oxide Delivery Systems Study
2.1Research Methodology for the Global Inhaled Nitric Oxide Delivery Systems Market
 2.1.1Main Objective of the Global Inhaled Nitric Oxide Delivery Systems Market
3MARKET SYNOPSIS

 

4EXECUTIVE SUMMARY

 

5COVID-19 IMPACT
6GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET REVENUE
7.1Paediatrics 
7.2Adults
8.1Hypoxic Respiratory Failure (HRF)
8.2Acute Hypoxemic Respiratory Failure (AHRF)
8.3Chronic Obstructive Pulmonary Disease (COPD)
8.4Others
9.1Disposables
9.2System
10.1Hospital
10.2Ambulatory Centers
10.3Clinics
11.1NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET 
 11.1.1United States
 11.1.2Canada 
 11.1.3Rest of North America
11.2EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET 
 11.2.1Germany 
 11.2.2France 
 11.2.3United Kingdom
 11.2.4Spain 
 11.2.5Italy 
 11.2.6Rest of Europe
11.3ASIA PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET
 11.3.1China 
 11.3.2Japan 
 11.3.3India 
 11.3.4Australia 
 11.3.5Rest of Asia Pacific
11.4REST OF THE WORLD INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET 
12.1Market Drivers 
12.2Market Challenges
12.3Impact Analysis
13INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET OPPORTUNITIES
14INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET TRENDS & INSIGHTS
15LEGAL & REGULATORY FRAMEWORK
16.1Demand Side Analysis
16.2Supply Side Analysis
 16.2.1Top Product Launches
 16.2.2Top Business Partnerships
 16.2.3Top Merger & Acquisitions
17VALUE CHAIN ANALYSIS
18.1Porter’s Five forces analysis
 18.1.1Bargaining power of Supplier
 18.1.2Bargaining power of Buyer
 18.1.3Industry Rivalry
 18.1.4Availability of Substitute
 18.1.5Threat of new Entrants
19.1Mallinckrodt Pharmaceuticals
 19.1.1Key Facts 
 19.1.2Business Description
 19.1.3Key Product/Services Offerings
 19.1.4Growth Strategy
 19.1.5SWOT Analysis
 19.1.6Key Financials
  19.1.6.1Revenue Split
  19.1.6.2Financial Overview of Mallinckrodt Pharmaceuticals
 19.1.7Recent Developments
  19.1.7.1Product Launch
  19.1.7.2Partnerships
  19.1.7.3Business Expansion and Investments
  19.1.7.4Merger and Acquisition
19.2Getinge  
19.3Vero Biotech 
19.4LINDE  
19.5Beyond Air 
19.6Air Liquide Healthcare
19.7Circassia Pharmaceuticals
19.8NU MED  
19.9Bellerophon Therapeutics
19.10Praxair Technology Inc.
20DISCLAIMER

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the global inhaled nitric oxide delivery systems market were the three major steps undertaken to create and analyze the adoption of inhaled nitric oxide delivery systems in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global inhaled nitric oxide delivery systems market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the inhaled nitric oxide delivery systems through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the inhaled nitric oxide delivery systems market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as type, application, product type, and end-users. Further country-level analyses were conducted to evaluate the overall adoption of inhaled nitric oxide delivery systems across the globe.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the practice management system. Further, we conducted factor analysis using dependent and independent variables such as technological advancement and the growing prevalence of respiratory diseases. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the inhaled nitric oxide delivery systems sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the inhaled nitric oxide delivery systems market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and the adoption rate of inhaled nitric oxide delivery systems across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the inhaled nitric oxide delivery systems market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Inhaled Nitric Oxide Delivery Systems Market

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the inhaled nitric oxide delivery systems market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type, applications, product type, and end-users of the inhaled nitric oxide delivery systems market.

The main objective of the Inhaled Nitric Oxide Delivery Systems Market Study

The current & future market trends of inhaled nitric oxide delivery systems were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of inhaled nitric oxide delivery systems in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of type, applications, product type, and end-users
  • Define and analysis of the regulatory framework for the inhaled nitric oxide delivery systems industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the inhaled nitric oxide delivery systems market for the major region
  • Major regions studied in the report include North America, Europe, Asia-Pacific, and Rest of the world
  • Company profiles of the inhaled nitric oxide delivery systems market and the growth strategies adopted by the market players to sustain in the fast-growing market

Deep dive regional level analysis of the industry